Ambroco United Siro Support Support Children (60ml)

Dosage form Syrup
Specifications Bottle x 60ml
Ingredient Ambroxol

Ingredient

Composition information	Content
Ambroxol	15mg

Uses

indications

AMBRCO 60 ml drug is indicated in the following cases:

Acute and chronic bronchial disease is related to abnormal mucus secretion and impaired mucus. The drug stimulates the mucus, and cut off the glycoprotein acid system in the mucus, causing the mucus to be less sticky. Ambroxol stimulates mucus to work and increase the cleaning ability of mucus, making spots dilute easier.

pharmacokinetic

Ambroxol is completely absorbed after drinking. Ambroxol reaches the maximum concentration in the blood within 0.5 to 3 hours and the semi -cancellation time is about 7-12 hours. About 1/3 of the dose is metabolized in the liver. Take multiple doses of ambroxol does not cause the accumulation of drugs. After drinking, about 85 - 90% of the drug is excreted in the urine. Less than 10% is excreted in constant form.

Before taking Ambroco United Siro Support Support Children (60ml)

How to use

Take medicine immediately after meals.

Dosage

Children under 2 years of age:

2.5 ml (1/2 teaspoon) 2 times/day

Children from 2 to 6 years old:

2.5 ml (1/2 teaspoon) 3 times/day

Children from 7 to 12 years old:

5 ml (1 teaspoon) 2-3 times/day

or as directed by the doctor.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.

What to do when overdose?

There is no related information.

In an emergency, call the 115 emergency center immediately or go to the nearest local health station.

What to do when forgetting a dose? However, if close to the next dose, skip the forgotten dose and take the next dose at the time as planned. Do not drink twice as prescribed.

Side Effects

When using 60 ml ambroco drugs, you may experience unwanted effects (ADR).

The frequency of unwanted effects is determined according to the following convention: Very common (> 1/10), common (1/100 to 1/10000 to

Common (1/100 to

Nervous system disorders: taste disorders (such as changing taste).

Respiratory disorders, chest and mediastinum: reduce the feeling of the pharyngeal area.

Digestive disorders: Nausea, decreased oral sensation.

Uncommon, 1/1000

Gastrointestinal disorders: vomiting, diarrhea, indigestion, abdominal pain, dry mouth.

Rare (1/10000 to

The immune system disorder: Hypersensitivity reaction.

Skin and subcutaneous tissue disorders: rash, urticaria.

Norbine reports (not estimated from available data)

Immune system disorders: Anaphylaxis including anaphylaxis, angioed and itching.

Digestive disorders: Dry throat.

Skin and subcutaneous disorders: Heavy skin reactions (including diverse roses, stevens-johnson syndrome/gangrene.

Please notify your doctor unwanted effects when taking the drug.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

Contraindicated

AMBRCO drug 60 ml contraindicated in the case:

Hypersensitivity to Ambroxol Hydrochloride or any ingredient of the drug.

Be cautious when using

very few reports of severe skin damage such as Stevens-Johnson syndrome and poisoned diagnosis (Ten) are related to the use of dragon-dragon drugs such as Ambroxol hydrochloride and are mainly explained due to the severity of the severe pathology and/or simultaneous use. Moreover, in the early stage of Stevens-Johnson or Ten's syndrome, the patient may first have a symptoms of nonsense such as fever, human pain, rhinitis, cough and sore throat. Symptoms such as the influenza can lead to improper treatment of symptoms by cough and colds. Therefore, if a new skin or mucosal damage appears, see a doctor immediately and should stop treating with ambroxol hydrochloride.

If there is a impaired renal function, it is recommended to use Ambroxol only after consulting the doctor.

Sorbitol excipients: Sorbitol -containing Sorbitol so that this drug should not be used in non -tolerant fructose - rare genetic diseases. The drug can cause mild laxative effect.

Paraben excipients: Data available from animal studies have no sufficient evidence related to the harmful effects of parabens in humans. However, more clinical data is needed to assess the potential risk of propylparaben in children under 2 years old. The use of drugs containing propylparaben in this age group needs to be adjusted depending on the specific circumstances, considering the benefits of treatment and risk.

The ability to drive and operate machinery

There is no evidence of the effect of drugs on driving and operating machinery.

Pregnancy

should be cautious when using drugs for pregnant women. Especially in the first three months of pregnancy, it is recommended not to use.

Breastfeeding period

Ambroxol Hydrochloride is secreted into breast milk. It is not recommended to use ambroxol for breastfeeding women, although there is no incomplete effect in breastfeeding children.

Drug interaction

There is no drug interaction with Ambroxol. Ambroxol can be used with other drugs, especially those commonly used in bronchial syndrome such as corticosteroids, bronchodilators, diuretic and antibiotics.

Storage

Store drugs at room temperature no more than 30 ° C. Use within 2 weeks after opening.

Expiry date: 24 months from the date of manufacture. Do not use overdue drugs stated on the packaging.

To be out of reach of children, read the instructions carefully before using if you need more information, please consult a doctor.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.